Sign in to view content

Risk for Sight-Threatening Diabetic Retinopathy With GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

Andrew J. Barkmeier, MD

Video
Published 2024

Related

Disparities in Utilization, Payments, and Follow-up of Teleophthalmology for Remote Diabetic Retinopathy Screening
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2024
Episode 5: Adding Dexamethasone Implant to Ranibizumab for Persistent DME with Dr. Raj Maturi
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017
Diabetic Retinopathy Progression in Anti-VEGF Versus Fluocinolone Acetonide Implant Treated Eyes Who Are Lost to Follow-up
Caesar K. Luo, MD, FASRS
Annual Meeting Talks
2020

Category: Diabetic Retinopathy

See more